2014年中美药理学发展研究比较

发布时间：2018-07-17 01:39

【摘要】：为了解中国与美国药理学学科发展的概况,该文研究了2014年中国作者与美国作者发表的药理学国际论文情况,并对其特点进行了比较分析,以指引我国药理学未来发展的方向。该研究在2013版期刊引证报告自然科学版药理学期刊中检索2014年中国学者与美国学者发文情况。结果表明,2014年中国作者共参与发表文献5 506篇,其中中国作者为第一/通讯作者的文献5 173篇;而美国作者参与发表文献量远高于中国作者,共发表11 256篇,其中美国作者为第一/通讯作者的文献9 470篇。从发文期刊上看,美国科研人员发文期刊影响因子更高,文章被引用次数也更多。从发文数量上看,植物药研究在我国药理学研究领域中占有重要地位,而美国药理学家则更注重应用性研究,神经药理为其重点关注的领域。中国作者发文涉及的机构大都为大学和高校,而在美国,除大学和高校外,企业也更多地参与到药理学研究中。结果提示,中国药理学研究虽然取得了长足的进步,但与发达国家相比仍有差距。中国药理学研究需立足自身特点,突出特色,加强创新,重视应用型研究。
[Abstract]:In order to understand the development of pharmacology in China and the United States, this paper studies the international papers on pharmacology published by Chinese and American authors in 2014, and makes a comparative analysis of their characteristics in order to guide the future development of pharmacology in China. In the 2013 edition of the journal citation report, the Chinese and American scholars were searched in the journal of pharmacology of natural science edition in 2014. The results showed that in 2014, Chinese authors participated in the publication of 5 506 articles, of which 5 173 were the first / corresponding authors, while the number of American authors was much higher than that of Chinese authors, with a total of 11 256 articles published. Among them, 9 470 articles were first / correspondence author in the United States. In terms of published journals, American researchers have higher influencing factors and more citations. In terms of the number of papers published, the research on plant medicine plays an important role in the field of pharmacological research in China, while the American pharmacologists pay more attention to the applied research, and neuropharmacology is the focus of attention. Most of the institutions involved in the Chinese authors' papers are universities and colleges, and in the United States, enterprises are more involved in pharmacological research than universities and colleges. The results suggest that although great progress has been made in pharmacological research in China, there is still a gap between China and developed countries. Chinese pharmacology research should be based on its own characteristics, highlight characteristics, strengthen innovation, and attach importance to applied research.
【作者单位】：中国医学科学院北京协和医学院药物研究所;中国药理学会;中国医学科学院医学信息研究所;
【基金】：中国科学技术协会学会能力提升专项-优秀科技社团奖国家科技部“重大新药创制”科技重大专项(No2013ZX09102106)
【分类号】：R96

【共引文献】